Nuclear Imaging

Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.

First participant of cohort 4 of the theranostic CL04 trial investigating 64Cu/67Cu SARTATE in neuroblastoma has been treated at the highest dose cohort of 375MBq/kg body weight using NorthStar’s electron accelerator-produced Cu-67, marking a key milestone in NorthStar’s agreement to exclusively supply Cu-67 to Clarity

News | Radiopharmaceuticals and Tracers

First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma

August 29, 2023 — NorthStar Medical Radioisotopes, LLC (“NorthStar"), a global innovator in the development, production ...

August 29, 2023

News | Radiopharmaceuticals and Tracers

Carolina Breast Imaging Specialists, PLLC Is First in Nation to Adopt Groundbreaking Imagio Breast Imaging System for Breast Cancer Diagnosis

August 29, 2023 — Mammograms are an essential part of preventive healthcare, and when an initial review reveals a ...

August 29, 2023

Strategic collaboration signed to support the development of radiopharmaceuticals in the fight against cancer

News | Radiopharmaceuticals and Tracers

PanTera and TerraPower Isotopes Join Forces to Accelerate Access to Actinium-225

August 28, 2023 — TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK CEN and IBA, announced that ...

August 28, 2023

Sponsored Content

Staging F-18 FDG PET/CT images of adenocarcinoma in the RUL of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. Images courtesy of Dr. Jay Kikut and UVM

Blog | PET-CT

Digital PET Balances Scan Time and Resolution

Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...

October 25, 2018

New UBC Okanagan research takes aim at improving diagnostic imaging

News | Radiology Imaging

Riding a Wave to Better Medical Diagnosis

August 24, 2023 — Medical imaging via X-rays, CT scans, MRIs and ultrasounds provide health-care professionals with ...

August 24, 2023

Radiopharmaceutical-directed treatment ushers in a new era of autonomous radiotherapy

News | Radiation Therapy

World’s First Cancer Patient Treated with RefleXion’s Breakthrough SCINTIX Biology-guided Radiotherapy

August 23, 2023 — RefleXion Medical, a therapeutic oncology company, today announced that the first patient has ...

August 23, 2023

Study investigated impact of radiographic media contrast shortage on stroke patient scan data

News | Contrast Media

Researchers Discover Contrast Dye Shortage Affected Assessment of Stroke Patients

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

August 17, 2023

In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy

News | Prostate Cancer

PSMA PET/CT Waives the Need for Pre-imaging Biopsy in Elderly Patients

August 15, 2023 — In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid ...

August 15, 2023

FDA-approved generic for MRI procedures is fully substitutable for Gadavist

News | Contrast Media

Fresenius Kabi Further Expands Radiology Portfolio with Launch of Gadobutrol Injection

August 8, 2023 — Fresenius Kabi announced it has launched Gadobutrol Injection, a generic substitute for the contrast ...

August 08, 2023

News | Radiation Therapy

RayCare in Clinical Use with CyberKnife at Lausanne University Hospital (CHUV) in Switzerland

August 3, 2023 —RaySearch Laboratories AB announced that Lausanne University Hospital (CHUV), Switzerland, has treated ...

August 03, 2023

Now radiology departments, imaging technologists and medical experts have a solution they can use to help tackle these challenges.

Sponsored Content | Case Study | Enterprise Imaging

Redefining Radiology

The healthcare industry faces many different types of obstacles in today’s challenging marketplace. Staff shortages ...

August 01, 2023

FDA-approved in May 2023, POSLUMA is commercially available through 36 radiopharmacies across the United States

News | Prostate Cancer

Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer

July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

July 28, 2023

Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design, that could help to create better images which help doctors diagnose patients’ conditions more easily and safely.

News | Magnetic Resonance Imaging (MRI)

Copper Could Help Create Clearer MRI Images and Improved Diagnosis

July 27, 2023 — Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design ...

July 27, 2023

Researchers at Monash University have designed a new co-training AI algorithm for medical imaging that can effectively mimic the process of seeking a second opinion.

News | PET Imaging

PSMA PET Imaging Improves Accuracy of Predicting Prostate Cancer Recurrence

July 26, 2023 — A molecular imaging tool developed by researchers at the University of California’s two nationally ...

July 26, 2023

A collaboration to advance development of a fibroblast activation protein (FAP)-targeted PET diagnostic compound for a broad array of epithelial-derived cancers.

News | Radiopharmaceuticals and Tracers

Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

July 25, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...

July 25, 2023

Positron Corporation has entered an Novation Agreement with Shenyang Intelligent Neuclear Medical Technology Co, LTD (Intelligent Neuclear Medical), a wholly owned subsidiary of Neusoft Medical Systems (Neusoft.

News | PET-CT

Positron Corporation Enters New Manufacturing & Components Supplier Cooperative with Neusoft Medical Systems Subsidiary for New PET-CT Device

July 25, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce that ...

July 25, 2023

Guerbet, a global specialist in contrast media and medical imaging solutions, announced the success of its teams at the PI-CAI (Prostate Imaging: Cancer Al) Grand Challenge

News | Prostate Cancer

Guerbet Wins PI-CAI Grand Challenge on Detection of Prostate Cancer

July 19, 2023 — Guerbet, a global specialist in contrast media and medical imaging solutions, announced the success of ...

July 19, 2023

NorthStar’s non-carrier added (n.c.a.) Ac-225 to be used in Bayer’s radiopharmaceutical programs

News | Molecular Imaging

NorthStar Medical Radioisotopes Executes Supply Agreement with Bayer for Therapeutic Radioisotope Actinium-225 (Ac-225)

July 18, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

July 18, 2023

With uMI Panorama, United Imaging Continues to Push the Envelope on Whole-Body System Performance

News | PET-CT

United Imaging Introduces Next-Generation PET/CT Systems and Integrated Molecular Technology Platform at SNMMI

July 12, 2023 — United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment and ...

July 12, 2023

For teleradiology groups, ensuring they have the radiologist capacity and technology in place will be essential to capitalize on the opportunity for robust market growth

Feature | Teleradiology | By Arun Gill

Outpatient Imaging And Teleradiology Changing the Market Dynamic in the US

The healthcare market is witnessing a dynamic shift in how and where patients want to receive care, with the flexibility ...

July 12, 2023

News | Radiopharmaceuticals and Tracers

First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

July 11, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...

July 11, 2023